文献速递胃肠外科围术期管理与 ERAS

胃癌手术中术中漏气试验与未行术中漏气试验术后结局比较:系统评价与Meta分析

A comparison of the postoperative outcomes between intraoperative leak testing and no intraoperative leak testing for gastric cancer surgery: a systematic review and meta-analysis.
PubMed 文献 · Surg Endosc · 2024-02-27

该系统评价与Meta分析检索PubMed、Embase和Cochrane Library数据库,纳入6项试验共1666例接受腹腔镜胃癌根治术的患者,比较术中漏气试验(IOLT)与未行术中漏气试验(NIOLT)的术后结局。结果显示IOLT组术后吻合口漏发生率、吻合口相关并发症发生率和再手术率均低于NIOLT组。作者认为IOLT似乎是胃癌手术中有前景的选择,但需进一步研究后才可能纳入未来临床指南。

要点

  • IOLT组术后吻合口漏发生率为2.09%,NIOLT组为6.68%(RR=0.31,95%CI 0.19-0.53,P<0.0001)。
  • IOLT组吻合口相关并发症发生率为3.24%,NIOLT组为10.85%(RR=0.30,95%CI 0.18-0.53,P<0.0001)。
  • IOLT组再手术率为0.94%,NIOLT组为6.83%(RR=0.18,95%CI 0.07-0.43,P=0.0002)。

核心结论

  • 考虑到观察到的术后吻合口漏、吻合口相关并发症和再手术率较低,IOLT似乎是胃癌手术中有前景的选择,但需进一步研究后才可能纳入未来临床指南。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Embase和Cochrane Library数据库的临床试验,纳入6项试验共1666例接受腹腔镜胃癌根治术的患者,比较IOLT与NIOLT的术后结局,并评估质量、异质性、偏倚风险及证据水平。

主要发现

  • IOLT组术后吻合口漏发生率为2.09%,NIOLT组为6.68%(RR=0.31,95%CI 0.19-0.53,P<0.0001)。
  • IOLT组吻合口相关并发症(包括出血、漏和狭窄)发生率为3.24%,NIOLT组为10.85%(RR=0.30,95%CI 0.18-0.53,P<0.0001)。
  • IOLT组再手术率为0.94%,NIOLT组为6.83%(RR=0.18,95%CI 0.07-0.43,P=0.0002)。
  • 统计异质性低。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文结论指出IOLT需进一步研究后才可能纳入未来临床指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative anastomotic leakage (PAL) is a serious complication of gastric cancer surgery. Although perioperative management has made considerable progress, anastomotic leakage (AL) cannot always be avoided. The purpose of this study is to evaluate whether intraoperative leak testing (IOLT) can reduce the incidence of PAL and other postoperative outcomes in gastric cancer surgery. MATERIALS AND METHODS: In this meta-analysis, we searched the PubMed, Embase, and Cochrane Library databases for clinical trials to assess the application of IOLT in gastric cancer surgery. All patients underwent laparoscopic radical gastrectomy for gastric cancer surgery. Studies comparing the postoperative outcomes of IOLT and no intraoperative leak testing (NIOLT) were included. Quality assessment, heterogeneity, risk of bias, and the level of evidence of the included studies were evaluated. PAL, anastomotic-related complications, 30-day mortality, and reoperation rates were compared between the IOLT and NIOLT group. RESULTS: Our literature search returned 721 results, from which six trials (a total of 1,666 patients) were included in our meta-analysis. Statistical heterogeneity was low. The primary outcome was PAL. IOLT reduced the incidence of PAL [2.09% vs 6.68%; (RR = 0.31, 95% Cl 0.19-0.53, P < 0.0001]. Anastomotic-related complications, which included bleeding, leakage, and stricture, were significantly higher in the NIOLT group than in the IOLT group [3.24% VS 10.85%; RR = 0.30, 95% Cl 0.18-0.53, P < 0.0001]. Moreover, IOLT was associated with lower reoperation rates [0.94% vs 6.83%; RR = 0.18, 95% CI 0.07-0.43, P = 0.0002]. CONCLUSION: Considering the observed lower incidence of postoperative anastomotic leakage (PAL), anastomotic-related complications, and reoperation rates, IOLT appears to be a promising option for gastric cancer surgery. It warrants further study before potential inclusion in future clinical guidelines.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Luo H, Liu S, Huang W, et al. A comparison of the postoperative outcomes between intraoperative leak testing and no intraoperative leak testing for gastric cancer surgery: a systematic review and meta-analysis. Surg Endosc. 2024. PMID: 38413470. doi:10.1007/s00464-024-10715-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。